BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+0.5%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.7B
AUM Growth
+$9.7B
(-1.5%)
Cap. Flow
+$400M
Cap. Flow
% of AUM
4.13%
Top 10 Holdings %
Top 10 Hldgs %
29.73%
Holding
233
New
14
Increased
61
Reduced
63
Closed
42
Top Buys
| 1 |
CareDx
CDNA
|
$65.3M |
| 2 |
Abbott
ABT
|
$50.4M |
| 3 |
Molina Healthcare
MOH
|
$46.5M |
| 4 |
Danaher
DHR
|
$44.5M |
| 5 |
Medtronic
MDT
|
$34M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$63.1M |
| 2 |
Centene
CNC
|
$40.7M |
| 3 |
Baxter International
BAX
|
$40.6M |
| 4 |
Hologic
HOLX
|
$22.3M |
| 5 |
DexCom
DXCM
|
$15.4M |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Technology | 0.8% |
| 3 | Industrials | 0.75% |
| 4 | Communication Services | 0.02% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Avantor
AVTR
$8.74B
| $21.6M | 0.22% |
512,216
| – | – |
|
|
NVRO
102
DELISTED
NEVRO CORP.
NVRO
| $19.3M | 0.2% |
237,841
+22,885
| +11% | +$1.86M |
|
103
Black Diamond Therapeutics
BDTX
$164M
| $18.5M | 0.19% |
3,463,000
| – | – |
|
104
Quanterix
QTRX
$202M
| $16.9M | 0.17% |
397,464
-196,355
| -33% | -$8.33M |
|
105
NeoGenomics
NEO
$1.06B
| $16M | 0.17% |
469,695
-91,988
| -16% | -$3.14M |
|
|
ONEM
106
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $14.7M | 0.15% |
836,190
| – | – |
|
107
Wave Life Sciences
WVE
$1.27B
| $14.5M | 0.15% |
4,602,858
+2,000,000
| +77% | +$6.28M |
|
108
Privia Health
PRVA
$2.85B
| $13.6M | 0.14% |
525,000
| – | – |
|
109
Amgen
AMGN
$153B
| $13.1M | 0.13% |
58,150
+24,200
| +71% | +$5.44M |
|
110
American Well
AMWL
$112M
| $12.9M | 0.13% |
106,392
| – | – |
|
111
Gilead Sciences
GILD
$140B
| $11.4M | 0.12% |
157,000
| – | – |
|
112
Transmedics
TMDX
$3.65B
| $11.1M | 0.11% |
581,029
| – | – |
|
113
Dentsply Sirona
XRAY
$2.77B
| $8.88M | 0.09% |
159,129
| – | – |
|
114
Zai Lab
ZLAB
$3.48B
| $7.96M | 0.08% |
126,600
+1,600
| +1% | +$101K |
|
|
SGEN
115
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.11M | 0.07% |
46,000
-7,400
| -14% | -$1.14M |
|
|
CELL
116
DELISTED
PhenomeX Inc. Common Stock
CELL
| $7M | 0.07% |
385,014
| – | – |
|
|
IMAB
117
I-MAB
IMAB
$380M
| $6.87M | 0.07% |
144,957
-18,000
| -11% | -$853K |
|
118
Pfizer
PFE
$141B
| $6.67M | 0.07% |
113,000
+13,400
| +13% | +$791K |
|
119
Q32 Bio
QTTB
$20.9M
| $6.32M | 0.07% |
96,507
| – | – |
|
120
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.31M | 0.07% |
71,400
+19,700
| +38% | +$1.74M |
|
|
ONC
121
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $6.23M | 0.06% |
23,000
| – | – |
|
122
Pulmonx
LUNG
$67.6M
| $5.66M | 0.06% |
176,510
| – | – |
|
123
Oscar Health
OSCR
$4.57B
| $5.34M | 0.06% |
679,952
| – | – |
|
124
Sight Sciences
SGHT
$199M
| $5.27M | 0.05% |
300,000
| – | – |
|
|
BHVN
125
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.24M | 0.05% |
38,007
+20,507
| +117% | +$2.83M |
|